Diagnostic and therapeutic approach to hypernatremia.
Ilardi A.
Diagnosis (Berl). 2022 Aug 2;9(4):403-410. doi: 10.1515/dx-2022-0034. eCollection 2022 Nov 1.
Evaluation and treatment of hypernatremia: a practical guide for physicians.
Liamis G, Filippatos TD, Elisaf MS.
Postgrad Med. 2016;128(3):299-306. doi: 10.1080/00325481.2016.1147322. Epub 2016 Feb 23.
Fluid Management.
Castera MR, Borhade MB.
2025 Apr 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
Electrolytes: Sodium Disorders.
Braun MM, Mahowald M.
FP Essent. 2017 Aug;459:11-20.
Pontine Myelinolysis Caused by Hypovolemic Hypernatremia.
Beraldo DO, Duarte SBCP, Santos RB, Mendes CG, Silveira MP, Neto AS, Silva MM, Oliveira LG, Bonfim AV, Teixeira AA, Teixeira RA.
Case Rep Nephrol. 2020 Sep 7;2020:4079098. doi: 10.1155/2020/4079098. eCollection 2020.
Encephalopathies caused by electrolyte disorders.
Samuels MA, Seifter JL.
Semin Neurol. 2011 Apr;31(2):135-8. doi: 10.1055/s-0031-1277983. Epub 2011 May 17.
Regional Citrate Anticoagulation versus No-Anticoagulation for Continuous Venovenous Hemofiltration in Acute Severe Hypernatremia Patients with Increased Bleeding Risk: A Retrospective Cohort Study.
Zhao L, Ma F, Yu Y, Li Y, Wang Y, He L, Zhou M, Tian X, Jing R, Li L, Li L, Huang C, Bai M, Sun S.
Blood Purif. 2020;49(1-2):44-54. doi: 10.1159/000502937. Epub 2019 Sep 13.
Fluid and Electrolyte Disturbances in COVID-19 and Their Complications.
Pourfridoni M, Abbasnia SM, Shafaei F, Razaviyan J, Heidari-Soureshjani R.
Biomed Res Int. 2021 Apr 14;2021:6667047. doi: 10.1155/2021/6667047. eCollection 2021.
Peritoneal dialysis solutions.
Gault MH.
Can Med Assoc J. 1973 Feb 3;108(3):325-7.
Interventions for chronic non-hypovolaemic hypotonic hyponatraemia.
Nagler EV, Haller MC, Van Biesen W, Vanholder R, Craig JC, Webster AC.
Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD010965. doi: 10.1002/14651858.CD010965.pub2.
